Astrana Health, Inc. (NASDAQ:ASTH) Shares Sold by Millennium Management LLC

Millennium Management LLC reduced its stake in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 56.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,433 shares of the company's stock after selling 9,700 shares during the quarter. Millennium Management LLC's holdings in Astrana Health were worth $234,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of ASTH. Pilgrim Partners Asia Pte Ltd bought a new stake in Astrana Health in the fourth quarter worth about $40,000. Quarry LP lifted its stake in Astrana Health by 35.5% in the fourth quarter. Quarry LP now owns 1,799 shares of the company's stock worth $57,000 after acquiring an additional 471 shares during the period. US Bancorp DE boosted its stake in shares of Astrana Health by 3,880.0% during the fourth quarter. US Bancorp DE now owns 4,776 shares of the company's stock valued at $151,000 after purchasing an additional 4,656 shares in the last quarter. Pictet Asset Management Holding SA increased its holdings in shares of Astrana Health by 21.9% in the 4th quarter. Pictet Asset Management Holding SA now owns 7,075 shares of the company's stock valued at $223,000 after acquiring an additional 1,273 shares during the period. Finally, Envestnet Asset Management Inc. lifted its position in shares of Astrana Health by 19.9% during the fourth quarter. Envestnet Asset Management Inc. now owns 7,124 shares of the company's stock valued at $225,000 after buying an additional 1,184 shares during the last quarter. Hedge funds and other institutional investors own 52.77% of the company's stock.

Astrana Health Trading Down 0.0%

NASDAQ ASTH traded down $0.01 during trading on Thursday, hitting $26.35. The stock had a trading volume of 213,050 shares, compared to its average volume of 292,607. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60. The company has a market capitalization of $1.48 billion, a PE ratio of 20.27, a PEG ratio of 1.37 and a beta of 0.85. The firm has a 50 day moving average price of $28.87 and a 200 day moving average price of $32.62. Astrana Health, Inc. has a twelve month low of $23.12 and a twelve month high of $63.20.

Astrana Health (NASDAQ:ASTH - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.23 by ($0.09). Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The company had revenue of $620.39 million for the quarter, compared to analysts' expectations of $628.11 million. During the same quarter last year, the company earned $0.31 EPS. Astrana Health's revenue for the quarter was up 53.4% compared to the same quarter last year. As a group, equities research analysts forecast that Astrana Health, Inc. will post 1.15 earnings per share for the current year.

Analysts Set New Price Targets

ASTH has been the subject of a number of recent analyst reports. Barclays assumed coverage on Astrana Health in a research report on Tuesday, April 1st. They issued an "equal weight" rating and a $36.00 price objective for the company. Bank of America cut their price target on Astrana Health from $55.00 to $49.00 and set a "buy" rating for the company in a research note on Tuesday, March 4th. Stifel Nicolaus reduced their price objective on shares of Astrana Health from $70.00 to $56.00 and set a "buy" rating for the company in a research report on Thursday, February 20th. Truist Financial decreased their price objective on Astrana Health from $50.00 to $46.00 and set a "buy" rating on the stock in a report on Tuesday, March 18th. Finally, Robert W. Baird dropped their price target on Astrana Health from $86.00 to $50.00 and set an "outperform" rating for the company in a research report on Monday, March 3rd. Three investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $53.29.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.